2024-11-19 18:41:46
Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate
Health/ 2023-07-22
Clover Biopharmaceuticals and Dynavax An...

Over 22,000 participants aged 18 years or older are expected to be enrolled in SPECTRA across Latin America,Asia,Europe and Africa

Ascentage Pharma's First Third-Generation BCR-ABL Inhibitor in China Olverembatinib (HQP1351) Recommended for Breakthrough Therapy Designation
Corporate/ 2023-07-23
Ascentage Pharma's First Third-Gene...

SUZHOU,ChinaandROCKVILLE,Md.,March 24,2021-- Ascentage Pharma (6855.HK),a globally focused,clinical-stage biotechnology company engaged in d...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release